BioAlliance Pharma announces participation in the Midcap Event on September 22 and 23, 2011

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to specialty and orphan oncology products, today announced that it will participate in the Midcap Event, a forum dedicated to meetings between institutional investors and listed companies from the Euronext Zone. The Midcap Event will take place on Thursday 22 and Friday 23 of September in Paris at the Palais Brongniart, 19 rue Notre-Dame des Victoires.
During these two days, Judith Greciet, CEO, and Nicolas Fellmann, Chief Financial Officer will meet with institutional investors to present BioAlliance Pharma’s development strategy, as well as the significant advances that were recently achieved.

110912EN_Midcap Event